Tom Bittick
Senior Product Manager of Oncology at Asuragen, a Bio-Techne brand.
False
Getting in Early on ESR1 Testing
April 8, 2025
This one simple change will improve monitoring of treatment resistance in metastatic breast cancer, says Tom Bittick
2 min read
Explore More in Pathology
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
Newsletters
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
